Innate and acquired immunity indices in assessing the clinical severity of patients with childhood schizophrenia

The results of previous studies suggest pathogenetic role of immune system in the development of schizophrenia. Examination of adolescent and young adult schizophrenic patients showed that the activity/ level of distinct parameters of innate and acquired immunity correlates with acuity and severity of pathological process in the brain. Presumably, evaluation of immune system characteristics in patients with childhood schizophrenia, concerning severity of their clinical symptoms, along with potential therapeutic aspect, may be the basis for early diagnosis of these conditions, and monitoring and prognosis of the further progression of the disease. The objective of our study was to compare clinical and immunological indices in children with schizophrenia to analyze the possibility of using these parameters for determination of the degree of activity of the pathological process. Sixty-two patients (39 boys and 23 girls) from 4 to 17 years of age with childhood schizophrenia were examined. Psychopathological and psychometric methods (PANSS and CGI-S scales) were used to assess mental state of the patients. Immunological parameters were determined in blood serum taken by fingerprick. Activity of leukocyte elastase (LE) and a1-proteinase inhibitor (a1-PI) was determined by spectrophotometric method. To determine the level of autoantibodies to S-100B and MBP, we used enzyme immunoassay. The study revealed activation of innate (by activity of LE and a1-PI) and acquired (by the level of autoantibodies to S-100B and MBP neuroantigens) immunity markers in blood serum of children with schizophrenia. Correlation analysis showed the significant positive correlation between complex evaluation of activation level of the immune system and severity of the patients’ state on the CGI-S scale (r = 0.64, p < 0.0001), as well as severity of negative symptoms according to the PANSS scale (r = 0.34, p = 0.0077). The revealed correlations suggest an opportunity for using immunological parameters (LE and a1-PI activity, and antibodies to neuroantigens), as the additional laboratory criteria for the assessment of clinical state in patients with childhood schizophrenia.

1. Buckley P.F. Neuroinflammation and schizophrenia. Curr. Psychiatry Rep., 2019, Vol. 21, no. 8, 72. doi: 10.1007/s11920-019-1050-z.

2. Dotsenko V.L., Neshkova E.A., Yarovaya G.A. Detection of human leukocyte elastase from the complex with plasma α1-proteinase inhibitor on the basis of its enzyme activity with a synthetic substrate. Problems of Medical Chemistry, 1994, Vol. 40, no. 30, pp. 20-25. (In Russ.)

3. Enache D., Pariante C.M., Mondelli V. Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue. Brain Behav. Immunol., 2019, Vol. 81, pp. 24-40.

4. Klyushnik T.P., Androsova L.V., Simashkova N.V., Zozulya S.A., Otman I.N., Koval-Zaytsev A.A. Innate and adaptive immunity in children with psychotic forms of autism-spectrum disorders. S. Korsakov Journal of Neurology and Psychiatry, 2011, Vol. 111, no. 8, pp. 41-45. (In Russ.)

5. Klyushnik T.P., Barkhatova A.N., Sheshenin V.S., Androsova L.V., Zozulya S.A., Otman I.N., Pochueva V.V. Specific features of immunological reactions in elderly and young patients with exacerbation of schizophrenia. S. Korsakov Journal of Neurology and Psychiatry, Vol. 121, no. 2, pp. 53-59. (In Russ.)

6. Klyushnik T.P., Smulevich A.B., Zozulya S.A., Voronova E.I. Neurobiology of schizophrenia (to the construction of clinical and biological model). Psychiatry, 2021, Vol. 19, no. 1, pp. 6-15. (In Russ.)

7. Klyushnik T.P., Zozulya S.A., Androsova L.V., Sarmanova Z.V., Otman I.N., Panteleeva G.P., Oleichik I.V., Kopeiko G.I., Borisova OA., Abramova L.I., Bologov P.V., Stolyarov S.A. Laboratory diagnostics in monitoring patients with endogenous psychoses (“Neuro-immuno-test.” Medical technology)]. Moscow: Medical Information Agency, 2016. 32 p.

8. Kose M., Pariante C.M, Dazzan P., Mondelli V. The role of peripheral inflammation in clinical outcome and brain imaging abnormalities in psychosis: a systematic review. Front. Psychiatry, 2021, Vol. 12, 612471. doi: 10.3389/fpsyt.2021.612471.

9. Miller B.J., Goldsmith D.R. Towards an immunophenotype of schizophrenia: progress, potential mechanisms, and future directions. Neuropsychopharmacology, 2017, Vol. 42, no. 1, pp. 299-317.

10. Nartikova V.F., Pashina T.S. A method for estimation of α1-antitrypsin and of α2-macroglobulin in human blood serum (plasma) in normal state and under some pathological conditions. Problems of Medical Chemistry, 1979, Vol. 25, no. 4, pp. 494-499. (In Russ.)

11. Otman I.N., Zozulya S.A., Chukanova A.S., Nadareishvili G.G., Simonov A.N., Gusev E.I., Klyushnik T.P. Immunological predictors of acute post-stroke period. S. Korsakov Journal of Neurology and Psychiatry, 2019, Vol. 119, no. 8, Iss. 2, pp. 39-45. (In Russ.)

12. Zozulya S.A., Otman I.N., Oleichik I.V., Anikhovskaya I.A., Yakovlev M.Yu., Klyushnik T.P. Conjugacy between processes of systemic inflammation and systemic endotoxinemia in endogenous psychoses. Siberian Herald of Psychiatry and Addiction Psychiatry, 2020, Vol. 3, no. 108, pp. 17-27. (In Russ.)